Vicore Pharma to Host Webcast to Discuss Buloxibutid and the Evolving ...
(PR-inside.com) STOCKHOLM, SE AND CAMBRIDGE, MA / ACCESS Newswire / June 2, 2026 / Vicore Pharma Holding AB (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 (AT2) receptor agonists, today announced that the company will host a webcast on Monday, June 8th, 2026, at 12:00 p.m. ET. The …
Short extract only — this publisher licenses its text. Read the full release at the source.
Free plan · Plus CA$29 or Pro CA$99/month


